Heme detoxification protein of Plasmodium falciparum (PfHDP)

The heme detoxification protein (PfHDP) of Plasmodium falciparum is an essential, parasite-specific enzyme responsible for converting toxic free heme, released during hemoglobin digestion, into chemically inert hemozoin crystals within the digestive vacuole of the parasite. This transformation protects the parasite from heme-induced oxidative stress, enabling its growth and proliferation inside human erythrocytes. PfHDP is unique among the genus Plasmodium, functional homologs exist in other malaria parasite species, but there is no equivalent process in the human host. Drugs such as chloroquine act by inhibiting this pathway, either by binding free heme to prevent crystallization or by disrupting PfHDP–heme interactions, resulting in toxic heme accumulation and parasite death. PfHDP's essentiality for malaria parasite survival and its distinct mechanism render it a high-value target for antimalarial drug development, though the complexity of the pathway and the parasite’s adaptive capacity pose therapeutic challenges. Other proteins associated with heme detoxification and hemoglobin digestion in P. falciparum include histidine-rich protein 2 (PfHRP-2), falcipain-2, plasmepsins, and falcilysin. PfHRP-2, in particular, serves as a scaffold for heme binding, and is used both as a diagnostic marker and for patient monitoring in malaria. The efficiency and essentiality of heme detoxification in P. falciparum make aspects of this pathway key points of vulnerability for antimalarial intervention.

Other names

Heme Detoxification Protein (HDP)PfHDPPlasmodium falciparum heme detoxification proteinPlasmodium heme detoxification proteinHz-producing enzyme (in reference to hemozoin formation)

Inhibition of hemozoin formation via binding to free heme, preventing its conversion to non-toxic hemozoin Disruption of HDP–heme interaction, leading to lethal accumulation of toxic heme Inhibition of hemoglobin digestion–heme detoxification coupling